Figure 1 (Memantine HCl Er Caps 28mg 8264 Lupin 1)
Memantine Hydrochloride Capsule, Extended Release
Product Images NDC 0615-8264
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 0615-8264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Memantine HCl Er Caps 28mg 8264 Lupin 2)
Figure 3 (Memantine HCl Er Caps 28mg 8264 Lupin 3)
Figure 4 (Memantine HCl Er Caps 28mg 8264 Lupin 4)
Figure 5 (Memantine HCl Er Caps 28mg 8264 Lupin 5)
Principal Display Panel (Memantine HCl ER Caps 28mg blistercard label)
This is a description of Memantine HCI ER Caps 28 mg drug which comes in a package of 30 capsules. It is manufactured by Lupin and packaged by Vangard in Glasgow, KY. It is recommended to be stored at 20°- 25°C (68°- 77° F) and dispensed in a tight container. Each capsule contains memantine hydrochloride USP 28 mg. See package insert or label for dosage information. The drug is for institutional use only. The text also contains lot numbers and expiration dates for different batches produced by Vangard, Glasgow.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
